Leukocyte tyrosine kinase (LTK) is a receptor tyrosine kinase which belongs to the insulin receptor superfamily and is mainly expressed in pre-B lymphocytes and neuronal tissues. Recently, we demonstrated that LTK utilizes Shc and IRS-1 as two major substrates and while both equally activate the Ras pathway, only IRS-1 suppresses apoptosis of hematopoietic cells, suggesting the existence of another unidenti®ed signaling pathway downstream of IRS-1, which is relevant to the antiapoptotic activity. In the present study, we found that wortmannin, a speci®c inhibitor of phosphatidylinositol 3' (PI3)-kinase, abolished the survival eects of LTK. Although c-Cbl is found to be phosphorylated by LTK and therefore is a second candidate linking LTK with the PI3-kinase pathway along with IRS-1, we found that the p85 subunit of PI3 kinase directly binds to tyrosine 753 of LTK, which is located within a YXXM motif, a consensus binding amino acid sequence for the SH2 domain of p85, but fails to bind to IRS-1 or c-Cbl. Ba/ F3 cells which stably express the EGF receptor-LTK chimeric receptor carrying a mutation at tyrosine 753 fell into apoptotic death even in the presence of EGF, indicating that the PI3 kinase pathway is required for the survival eects of LTK.
Introduction
Leukocyte tyrosine kinase (LTK) is a receptor tyrosine kinase which belongs to the insulin receptor superfamily and is mainly expressed in pre-B cells and neuronal tissues (Ben-Neriah and Bauskin, 1988; Maru et al., 1990; Toyoshima et al., 1993) . Although ligands for LTK have not been identi®ed yet, the analyses of ALK tyrosine kinase which was cloned by the positional cloning strategy from the breakpoint of the t(2;5)(p23;q35) chromosomal translocation, suggest that these two tyrosine kinases are structurally and functionally closely related to each other and they may form a new subfamily in the insulin receptor superfamily (Morris et al., 1994; Fujimoto et al., 1996) . In previous studies, we have demonstrted that LTK utilizes two major signaling molecules, Shc, which binds to tyrosine 862 at the carboxyl-terminal domain, and IRS-1, which binds to tyrosine 485 at the juxtamembrane domain. Both tyrosines are located within the NPXY motifs, which are consensus binding motifs for the phosphotyrosine-binding (PTB) domains of Shc and IRS-1 (Kavanaugh and Williams, 1994; Craparo et al., 1995; Gustafson et al., 1995) . We examined the roles of two signaling molecules in the LTK signaling pathway and found that these two molecules equally stimulate the growth signals transmitted through the Ras pathway but only IRS-1 transmits anti-apoptotic signals at least in Ba/F3 cells (Ueno et al., 1995; . These ®ndings indicate that, to maintain continuous expansion of hematopoietic cells, both growth signals and anti-apoptotic signals are required. Recently it was reported that the phosphatidylinositol 3' (PI3)-kinase pathway is required for survival signals of trk and PDGF receptor (Yao and Cooper, 1995; . Because IRS-1 is known to associate with the p85 subunit of PI3 kinase when phosphorylated by insulin or interleukin 4 Myers et al., 1993 Myers et al., , 1994 Wang et al., 1993) , we hypothesized that the PI3 kinase pathway plays an important role in anti-apoptotic eects of LTK. Moreover, we found that c-Cbl proto-oncogene product is phosphorylated on tyrosine residues by LTK. Therefore, along with IRS-1, c-Cbl is a candidate which links LTK with the PI3-kinase pathway. In this study, we examined the mechanism how LTK activates the PI3 kinase pathway and the role of the PI3 kinase pathway in the survival eects of LTK.
Results

The survival signal of LTK is sensitive to wortmannin
We recently showed that two distinct NPXY motifs located at the cytoplasmic domain of LTK are critical for transmitting growth and survival signals. One is from asparagine 482 to tyrosine 485 at the juxtamembrane domain which is the binding site for IRS-1 and another is from asparagine 859 to tyrosine 862 at the carboxyl terminal domain which is the binding site for Shc. Our data indicate the survival signal of LTK is mainly generated through Y-485, which is critical for IRS-1 phosphorylation. We ®rst intended to characterize the survival signal transmitted via IRS-1. Because insulin or IL-4 induces tyrosine phosphorylation of IRS-1 and its association with the p85 subunit of PI3 kinase Myers et al., 1993 Myers et al., , 1994 Wang et al., 1993) , we tested if wortmannin, a speci®c inhibitor for PI3 kinase, aects the survival signal of LTK. We have established EL, which is a stable line of Ba/F3 cells expressing the EGF receptor-LTK chimeric receptor and EL-Y862F, which expresses the mutant chimeric receptors in which the indicated tyrosine is mutated to phenylalanine. EL-Y862F cells can not phosphorylate Shc but, by phosphorylating IRS-1, can survive for more than a week in the presence of EGF (Ueno et al., 1996) . Therefore by using EL-Y862F cells, we can analyse survival eects of IRS-1. We cultured these cell lines in the presence of EGF with or without wortmannin, ®nding that wortmannin induced apoptosis in both EL and EL-Y862F cells within 2 days (Figure 1a, b) . These results indicate that the PI3 kinase pathway is required for the surivival signal of LTK.
LTK phosphorylates c-Cbl and induces its association with a 52 kDa phosphoprotein Since a 120 kDa protein is inducibly phosphorylated in EL cells on tyrosine residues upon EGF treatment (data not shown), we searched for signaling molecules with approximately 120 kDa that are phosphorylated by LTK, eventually ®nding that c-Cbl is a substrate for LTK (Figure 2a) . The c-Cbl proto-oncogene was originally identi®ed as a cellular homologue of v-Cbl oncogene, which was cloned from the Cas NS-1 murine leukemia virus (Langdon et al., 1989) . Upon phosphorylation, c-Cbl can bind to the SH2 domains of the p85 subunit of PI3 kinase and CRK (Sawasdikosol et al., 1995; Panchamoorthy et al., 1996; Reedquist et al., 1996) . Therefore c-Cbl can act as an adaptor protein which connects LTK with the PI3 kinase pathway.
When the lysates from EL cells stimulated with EGF were immunoprecipitated with anti-c-Cbl antibody, a 52 kDa phosphoprotein was co-precipitated with c-Cbl (Figure 2a ). This phosphoprotein was reacted with anti-Shc antibody (data not shown). However, 46 kDa and 66 kDa Shc proteins were not detected in this experiment. Previously we have shown that Shc is a substrate of LTK, which binds to the NPXY sequence at the carboxyl terminal domain (amino acids 859 ± 862) and connects Grb2 and LTK (Ueno et al., 1995) . Because c-Cbl is known to associate with Shc and Grb2 (Odai et al., 1995; Fukazawa et al., 1996; Panchamoorthy et al., 1996) , we hypothesized that tyrosine 862 is critical for c-Cbl phosphorylation. To test this, we examined if several mutant EL receptors can phosphorylate c-Cbl. As expected, we found that EL-Y862F mutant receptor could not eciently phosphorylate c-Cbl as the wild-type EL receptor whereas EL-Y485F receptor could (Figure 2b ). These data indicate that tyrosine 862 is required for phosphorylation of c-Cbl and suggest that c-Cbl binds to tyrosine 862 of LTK via Shc or Grb2.
The p85 subunit of PI3-kinase associates with LTK but not with IRS-1 or c-Cbl
At this point, it becomes clear that LTK kinase has at least two adaptor molecules which link LTK with the PI3 kinase pathway, IRS-1 and c-Cbl. To test which molecule is the major adaptor protein connecting LTK with the PI3 kinase pathway, we examined which is the major molecule co-immunopecipitated with anti-p85 antibody. Lysates from EL cells stimulated with EGF were immunopecipitated with anti-p85 antibody, followed by the immunoblotting with anti-phosphotyrosine antibody. Surprisingly, we found in this experiment that p85 could not co-precipitate c-Cbl (120 kDa) nor IRS-1 (180 kDa) at least at a detectable level by the immunoblotting with anti-phosphotyrosine antibody. Instead, it could co-precipitate a 140 kDa phosphoprotein ( Figure 3a ). This 140 kDa protein was recognized by anti-LTK antibody and therefore is the EL chimeric receptor itself (data not shown). This result suggests that p85 directly binds to LTK but not with neither IRS-1 nor c-Cbl as an adaptor molecule.
The binding site of LTK with p85 subunit of PI3-kinase is Tyr-753
The consensus amino acid sequence which is recognized by the SH2 domain of p85 subunit of PI3 kinase is a YXXM motif (Songyang et al., 1993 (Songyang et al., , 1994 . LTK has one YXXM motif on the cytoplasmic region at tyrosine 753. To test if the p85 subunit can bind to tyrosine 753, we constructed an EL-Y753F chimeric receptor in which tyrosine 753 is mutated to phenylalanine and established a stable line, EL-Y753F, which expresses EL-Y753F receptors. We con®rmed that the EL-Y753F chimeric receptor was expressed and inducibly phosphorylated by EGF treatment as the wild-type EL receptor (Figure 3b ).
Lysates from EL-Y753F cells stimulated with EGF were immunoprecipitated with anti-p85 antibody and examined if EL-Y753F receptor was co-immunoprecipitated with anti-p85 antibody as was the wild-type EL receptor. In this experiment, EL-Y753F receptor was not co-immunoprecipitated with anti-p85 antibody, indicating that the binding site for p85 is tyrosine 753 (Figure 3a) . From these results, we propose a possible scheme of the LTK signaling pathway and its relationship with the PI3 kinase pathway in Figure 4 . We suggest that p85, unlike the insulin receptor, binds directly to the cytoplasmic domain of LTK, not via IRS-1 nor c-Cbl.
The mutation at tyrosine 753 reduces the PI3 kinase activity and abolished the survival signals of LTK Because wortmannin induced apoptosis of EL cells even in the presence of EGF, we hypothesized that the PI3 kinase activity is required for the survival signal of LTK. If, as presented in Figure 4 , activation of PI3 kinase by LTK is mainly generated via tyrosine 753, the EL-Y753 receptor could neither activate the PI3 kinase pathway nor generate the survival signals. We ®rst examined the PI3 kinase activity of EL and EL-Y753F cells in the presence or absence of EGF. In this experiment, we found that the PI3 kinase activity of EL-Y753F cells stimulated with EGF was signi®cantly reduced when compared with that of EL cells (Figure 5a, b) . We cultured EL-Y753F cells and EL cells in the presence of EGF and found that while EL cells continuously proliferated, EL-Y753F cells rapidly fell into apoptotic death within 2 days ( Figure  6a ). The low molecular weight DNA from EL-Y753F cells cultured for 2 days in the presence of EGF showed laddering typical for apoptotic death ( Figure  6b ). These results suggest that tyrosine 753 of LTK is critical for connecting LTK with the PI3 kinase pathway and is required for generating the antiapoptotic activity.
Discussion
Our fundamental hypothesis in this study is that not only growth signals but also survival signals are required for continuous expansion of animal cells. Many studies focused on the cell growth signals revealed importance of activation of the Ras pathway. On the other hand, it has been shown that EL-Y753 cells fell into apoptotic death within two days even in the presence of EGF. EL and EL-Y753F cells were cultured in the medium containing EGF (20 ng/ml) for 2 days. Then low molecular weight DNAs were extracted from these cells and separated by 2% agarose gel electrophoresis activation of the Ras pathway is not enough to sustain the continuous expansion of hematopoietic cells (Shibuya et al., 1992) , indicting that other kinds of signals are also required. Many studies have indicated that growth factors not only stimulate the growth of cells but also prevent cells from apoptotic death. Deprivation of these`survival' signals results in apoptotic cell death even if growth signals are generated. This dual regulation of cell growth and survival may be important for avoiding unnecessary growth of animal tissues, especially in the immunological systems.
We have been studying the signal transduction pathway of LTK by an approach using chimeric receptors, ®nding that it is similar to that of insulin receptor in that it utilizes Shc and IRS-1 as two major substrates. Interestingly, unlike the insulin receptor, the binding sites for them on the cytoplasmic domain of LTK are separated. This enabled us to analyse the distinctive roles of IRS-1 and Shc in the cell growth and survival signals of LTK. We found in these experiments that, while both molecules transmitted cell growth signals, only IRS-1 generated antiapoptotic signals (Ueno et al., 1995; . In the present study, we ®rst tried to further characterize the signaling pathway responsible for the cell survival which is downstream of tyrosine 485, the binding site for IRS-1. Because the PI3 kinase pathway, which has been shown to be critical for survival signals in the TRK and PDGF receptor signaling Cooper, 1995, 1996) , we hypothesized the PI3 kinase pathway is critical for the survival signal of LTK. Supporting this hypothesis, wortmannin, a speci®c inhibitor of the PI3 kinase pathway, induced apoptotic death of EL cells cultured in the presence of EGF. Furthermore, we found in this study that c-Cbl, which has been shown to bind to p85 upon T cell receptor activation , is phosphorylated by LTK. Therefore c-Cbl is a next candidate adaptor connecting LTK with the PI3 kinase pathway. While p85 subunit co-precipitated the EL receptor itself, it did not coprecipitate IRS-1 nor c-Cbl at least at a detectable level by the immunoblotting, indicating that the cytoplasmic domain of LTK directly binds to p85. The mutation at tyrosine 753, which is located in YXXM motif, a consensus amino acid sequence of the binding site for the SH2 domain of p85, completely abolished the association between p85 and LTK. Together with the data that EL-Y753F cells fell into apoptotic death even in the presence of EGF, the major pathway connecting LTK with the PI3 kinase pathway is via tyrosine 753. This is quite dierent from the signaling pathway of insulin receptor. Interestingly, the YXXM motif is also conserved in the cytoplasmic domain of ALK, which is closely related to LTK tyrosine kinase, suggesting the important role of the PI3 kinase pathway in the signaling pathway of the LTK subfamily of the insulin receptor superfamily.
From the data presented in this study, we can conclude that the PI3 kinase pathway is required for the survival signal of LTK. However it does not mean that activation of the PI3 kinase pathway is sucient, since we have shown that tyrosine 485 of LTK is also required to generate survival signals (Ueno et al., 1996) . Because our data show that p85 directly binds to tyrosine 753 of LTK, we suggest that the survival signal transmitted via tyrosine 485, which is the binding site for IRS-1, is distinct from the PI3 kinase pathway. The survival signals of LTK may be composed of several signaling pathway including the PI3 kinase pathway and other unidenti®ed pathways.
To clarify the mechanism how survival signals are generated, more detailed analyses of signaling systems for many growth factor receptors will be needed.
Materials and methods
Cells and antibodies
Ba/F3 cells were cultured in RPMI1640 containing 10% FCS and 0.25 mg/ml of mouse interleukin 3. Anti-c-Cbl antibody, anti-phosphotyrosine antibody 4G10 and anti-EGF receptor antibody, Ab-1 was purchased from Santa Cruz Biotechnology Inc, Upstate Biotechnology Inc and Oncogene Science Inc, respectively. Anti-p85 antibody was gifted by Y Fukui (University of Tokyo, Tokyo). Anti-LTK monoclonal antibody, 1D3-1 was described previously (Toyoshima et al., 1993) .
Construction of cDNAs for EGFR-LTK chimeric receptors and LTK mutant
The EGFR-LTK chimeric receptor (EL) cDNA was constructed by ligating the extracellular domain of human EGFR with the transmembrane and the cytoplasmic domains of LTK (Ueno et al., 1995) . Tyrosine-phenylalanine LTK mutants, Y753F and Y862F were generated as described elsewhere (Kozutsumi et al., 1994; Ueno et al., 1995) . To construct mutant chimeric receptors, the HindIII ± EcoRV fragments of the mutant LTK cDNAs which encode the cytoplasmic domain were substituted for that of wild-type EL receptor cDNA. Retrovirus vector was used to transfect cDNAs of mutant chimeric receptors into Ba/F3 cells as described previously (Ueno et al., 1996) .
Immunoprecipitation and immunoblotting
Prior to stimulation, cells were starved in RPMI containing 0.5% FCS for 12 h. Cells were then stimulated with 200 mg/ml of human EGF (WAKUNAGA Inc) for 5 min at 378C, washed twice with ice-cold phosphate-buered saline (PBS), and lysed in Triton lysis buer (0.5% (v/v) Triton X-100, 50 mM Tris-HCl pH 7.4, 2 mM PMSF, 10 units/ml aprotinin, 1 mM sodium orthovanadate, 1 mM EDTA). Cell lysates were collected and subjected to immunoprecipitation and immunoblotting as described previously (Ueno et al., 1995 (Ueno et al., , 1996 . The immunoblots were developed with the ProtoBlot system (Promega) or the ECL system (Amersham).
Measurement of PI3-kinase activity PI3-kinase activity was measured as described (Yamauchi et al., 1996) previously. Brie¯y, the anti-p85 immunoprecipitates were washed four times in PI3K buer (20 mM, Tris-HCl pH 7.5, 100 mM NaCl, 0.5 mM EGTA). Then crude brain phosphoinositides (Sigma, P6023) were added to the immunoprecipitates at a ®nal concentration of 0.2 mg/ml. The [g-32 P]ATP, ATP and MgCl 2 were added and incubated for 20 min at room temperature. The lipids were extracted into a chloroform/methanol mixture (1 : 1, v/v). The lipids-containing organic phase was resolved on thin layer chromatography (TLC) plates (Silica Gel 60; MCB reagents, Merick), developed in chloroform/methanol/ammonia solution (28%)/water (215 : 190 : 25 : 35 mixture) and visualized by autoradiography.
Analysis of chromosomal DNA fragmentation
To extract the fragmented DNA observed during apoptotic death, 5610 6 cells were collected and lysed with 400 ml of lysis buer (10 mM Tris-HCl, pH 7.5, 10 mM EDTA, 0.2% Triton X-100). The lysate was kept on ice for 10 min and centrifuged at 15 000 r.p.m. for 10 min. The supernatant was subjected to extraction with phenol/chloroform/ isoamylalcohol (25;24;1) followed by ethanol precipitation. The precipitate was dissolved in 20 ml of TE and incubated for 1 h with RNase A (2 mg/ml) at 378C. DNA fragments were separated by 2% agarose gel electrophoresis and visualized by ethidium bromide staining.
